×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

  • Gurus
  • Other
  • VIVO CAPITAL, LLC (Data extracted from 13F, 13D, 13G and Form 4)

VIVO CAPITAL, LLC

AUM: $5.81 B
13-F Portfolio Value: $1.24 B
Last 13-F Filed: Q3 2025
Concentration in top 10: 58%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
TRVITrevi Therapeutics Inc3.75%5,094,668$46,616,212606,76513.52%$9.1513F
COGTCogent Biosciences Inc3.22%2,789,137$40,052,0071,666,666148.48%$14.3613F
CMPXCompass Therapeutics Inc2.69%9,545,466$33,409,1313,502,00057.95%$3.513F
DYNDyne Therapeutics Inc2.66%2,614,960$33,079,2441,500,000134.53%$12.6513F
DRUGBright Minds Biosciences Inc2.45%501,617$30,428,087250,04599.39%$60.6613F
VSTMVerastem Inc1.88%2,644,985$23,355,2181,106,52471.92%$8.8313F
ERASErasca Inc1.63%9,273,428$20,216,0732,516,67237.25%$2.1813F
PRAXPraxis Precision Medicines0.85%198,895$10,541,43531,29518.67%$5313F
UNCYUnicycive Therapeutics0.63%1,789,916$7,804,034652,90157.42%$4.3613F
TNGXTango Therapeutics Inc0.53%776,699$6,524,272176,69929.45%$8.413F